✦ LIBER ✦

49 Non-proteolytic role of urokinase-type plasminogen activator system in human breast cancer cells migration

✍ Scribed by Bénédicte Chazaud; Rémy Ricoux; Romain K. Gherardi; Anders Nykjaer; Georgia Barlovatz-Meimon

Book ID: 117439426
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 127 KB
Volume: 11
Category: Article
ISSN: 0268-9499
DOI: 10.1016/s0268-9499(97)80164-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of urokinase plasminogen activator

Role of urokinase plasminogen activator in human breast cancer: Active involvement of stromal fibroblasts

✍ C.E.P. van Roozendaal; J.G.M. Klijn; A.M. Sieuwerts; S.C. Henzen-Logmans; J.A. F 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 897 KB

Prognostic significance of the urokinase

Prognostic significance of the urokinase type plasminogen activator (u-PA) system in node-negative breast cancer

✍ Eiichi Shiba; Seung Jin Kim; Tetsuya Taguchi; Fumine Tsukamoto; Shinzaburo Noguc 📂 Article 📅 1999 🏛 Springer Japan 🌐 English ⚖ 329 KB

Induction of Urokinase-Type Plasminogen

Induction of Urokinase-Type Plasminogen Activator by Lipopolysaccharide in PC-3 Human Prostatic Cancer Cells

✍ Shoichiro Ohta; Kenji Niiya; Nobuo Sakuragawa; Hideki Fuse 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Induction of c-fos gene expression by ur

Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells

✍ I. Dumler; T. Petri; W.-D. Schleuning 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 678 KB

Thrombospondin and transforming growth f

Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells

✍ Juan P. Arnoletti; Daniel Albo; Mark S. Granick; Mark P. Solomon; Analia Castigl 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 860 KB

The insulin-like growth factor-1 elevate

The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: A new avenue for breast cancer therapy

✍ S.E. Dunn; J.V. Torres; N. Nihei; J.C. Barrett 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 1 views

Tumor recurrence is a common problem in the treatment of breast cancer. In breast cancer, the expression of high protein levels of the insulin-like growth factor-1 receptor (IGF-1R) and urokinase-type plasminogen activator-1 (uPA) is strongly associated with breast cancer recurrence and decreased su